BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 35272690)

  • 1. Rare occurrence of pseudomyxoma peritonei (PMP) syndrome arising from a malignant transformed ovarian primary mature cystic teratoma treated by cytoreductive surgery and HIPEC: a case report.
    Ponzini F; Kowal L; Ghafoor M; Goldberg A; Chan J; Lamm R; Cannaday SM; Richard SD; Nevler A; Lavu H; Bowne WB; Rosenblum NG
    World J Surg Oncol; 2022 Mar; 20(1):78. PubMed ID: 35272690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucinous tumors arising in ovarian mature cystic teratomas: relationship to the clinical syndrome of pseudomyxoma peritonei.
    Ronnett BM; Seidman JD
    Am J Surg Pathol; 2003 May; 27(5):650-7. PubMed ID: 12717249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
    McKenney JK; Soslow RA; Longacre TA
    Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D; Kusamura S; Nonaka D; Langer M; Andreola S; Favaro M; Gavazzi C; Laterza B; Deraco M
    Ann Surg Oncol; 2008 Feb; 15(2):526-34. PubMed ID: 18043976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian mucinous tumour arising in mature cystic teratoma and associated with pseudomyxoma peritonei: report of two cases and comparison with ovarian involvement by low-grade appendiceal mucinous tumour.
    Stewart CJ; Tsukamoto T; Cooke B; Leung YC; Hammond IG
    Pathology; 2006 Dec; 38(6):534-8. PubMed ID: 17393980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of pseudomyxoma peritonei arising from a perforated intraductal papillary mucinous neoplasm that underwent cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Yoshizaki Y; Gohda Y; Inagaki F; Kataoka A; Takemura N; Miyazaki H; Igari T; Kiyomatsu T; Yano H; Kokudo N
    Clin J Gastroenterol; 2024 Feb; 17(1):188-197. PubMed ID: 37980306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
    Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
    In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing long-term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei originating from appendiceal neoplasms.
    van Eden WJ; Kok NFM; Snaebjornsson P; Jóźwiak K; Woensdregt K; Bottenberg PD; Boot H; Aalbers AGJ
    BJS Open; 2019 Jun; 3(3):376-386. PubMed ID: 31183454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudomyxoma peritonei associated with a mucinous ovarian tumor arising from a mature cystic teratoma. A case report.
    Marquette S; Amant F; Vergote I; Moerman P
    Int J Gynecol Pathol; 2006 Oct; 25(4):340-3. PubMed ID: 16990709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy to Treat Pseudomyxoma Peritonei of Ovarian Origin: A Retrospective French RENAPE Group Study.
    Trecourt A; Bakrin N; Glehen O; Gertych W; Villeneuve L; Isaac S; Benzerdjeb N; Fontaine J; Genestie C; Dartigues P; Leroux A; Quenet F; Marchal F; Odin C; Khellaf L; Svrcek M; Thierry S; Augros M; Omar A; Devouassoux-Shisheboran M; Kepenekian V;
    Ann Surg Oncol; 2024 May; 31(5):3325-3338. PubMed ID: 38341381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Borderline-like mucinous tumor arising in mature cystic teratoma of the ovary associated with pseudomyxoma peritonei.
    Hwang JH; So KA; Modi G; Lee JK; Lee NW; Lee KW; Kim I
    Int J Gynecol Pathol; 2009 Jul; 28(4):376-80. PubMed ID: 19483624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unusual site of pseudomyxoma peritonei recurrence after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a case report of intraluminal disease manifestation in the small bowel.
    Rauwerdink P; Brosens LAA; van Diepen KK; Ghedri ON; Kranenburg O; Boerma D; Witkamp AJ; van Grevenstein HMU
    World J Surg Oncol; 2022 May; 20(1):147. PubMed ID: 35538541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Cancer Diaspora: A Rare Case of Pseudomyxoma Peritonei of Appendiceal Origin.
    Bathobakae L; Ozgur SS; Jariwala M; Kesrani J; Ajas S; Kumar M; Akmal A
    J Investig Med High Impact Case Rep; 2023; 11():23247096231217822. PubMed ID: 38102072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomyxoma Peritonei of Extra-Appendiceal Origin: A Comparative Study.
    Baratti D; Kusamura S; Milione M; Pietrantonio F; Caporale M; Guaglio M; Deraco M
    Ann Surg Oncol; 2016 Dec; 23(13):4222-4230. PubMed ID: 27352203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperthermic intraperitoneal chemotherapy in patients with incomplete cytoreduction for appendiceal pseudomyxoma peritonei: a 10-year treatment experience in China.
    Wang B; Ma R; Shi G; Fan X; Rao B; Xu H
    Orphanet J Rare Dis; 2024 Jan; 19(1):8. PubMed ID: 38178189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathologic diagnosis, origin, and natural history of pseudomyxoma peritonei.
    Buell-Gutbrod R; Gwin K
    Am Soc Clin Oncol Educ Book; 2013; ():221-5. PubMed ID: 23714507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic chemotherapy: a 7-year single-center experience.
    Virzì S; Iusco D; Bonomi S; Grassi A
    Tumori; 2012; 98(5):588-93. PubMed ID: 23235753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei in a liver-transplanted patient: a case report.
    Thorgersen EB; Melum E; Folseraas T; Larsen SG; Line PD
    World J Surg Oncol; 2018 Sep; 16(1):180. PubMed ID: 30185175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Arising from Urachus.
    Liu Y; Ishibashi H; Hirano M; Takeshita K; Mizumoto A; Ichinose M; Nishino E; Kashu I; Yamamoto Y; Sugarbaker PH; Yonemura Y
    Ann Surg Oncol; 2015 Aug; 22(8):2799-805. PubMed ID: 25572681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of Pseudomyxoma Peritonei of an unexpected origin.
    Csanyi-Bastien M; Blanchard F; Lamy A; Sabourin JC
    Diagn Pathol; 2021 Dec; 16(1):119. PubMed ID: 34930348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.